Mapping Global Scientific Production on Human Immunodeficiency Virus and Monkeypox: A Scientometric Study

ABSTRACTBackground and AimHIV attacks the immune system, leading to AIDS if untreated. Mpox, a zoonotic disease like smallpox, is less severe but poses higher risks for immuno‐compromised individuals, especially those with HIV. Effective prevention and treatment are crucial. This study aims to assess the global academic output on Monkeypox (MPVX) and HIV during 2018–2023.MethodsThis descriptive, bibliometric study reviewed the published literature on “monkeypox” and “HIV” during the period 2018–2023. The search was conducted on February 11, 2024, using a systematic formula. We identified 366 potential articles, including various types of papers. When exporting metadata to SciVal for the period 2018–2023, 8 metadata could not be exported. The remaining data were analyzed using SciVal and Bibliometrix in R Studio, providing an overview of research productivity, collaborations, and citation impact.ResultsDuring the period 2018–2023, 366 papers on “monkeypox” and “HIV” were published in 183 different sources, with an annual growth rate of 208.18%. These papers had an average of 14.78 citations per paper. An additional 2522 keywords and 638 author keywords were identified. The “Journal of Medical Virology” led the academic output with 20 papers, followed by “The Lancet Infectious Diseases” with 11 papers. The “Institut national de la santé et de la recherche médicale” in France led the academic output. These data are specific to papers dealing with “monkeypox” and “HIV.”ConclusionResearch on Monkeypox and HIV has grown significantly during the period studied, with remarkable international collaboration. These findings underscore the importance and global impact of Monkeypox and HIV research.